Syntese Competitors and Similar CompaniesClear all
Syntese's competitors and similar companies include Zealand Pharma, Hansoh Pharma, Catalent and PPD.
 Syntese Syntese is a company manufacturing Mesalazine, an active pharmaceutical ingredient (API) used in treating inflammatory bowel diseases. |  Zealand Pharma Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. | ||
Founding Date | Founding Date 1989 | Founding Date 1998 | Founding Date 1995 | Founding Date 2007 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Hvidovre, DK HQ | Locations Søborg, DK HQ Boston, US Marlborough, US | Locations Shanghai, CN HQ | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more |
Employees | Employees 1322% increase | Employees 385 | Employees 8,989 | Employees 12,6955% increase | Employees 24,5842% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr9.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) $4.7b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods kr816k (FY, 2025) | Cost of goods N/A | Cost of goods $3.4b (FY, 2024) | Cost of goods $1.7b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit kr9.3b (FY, 2025) | Gross profit N/A | Gross profit $953m (FY, 2024) | Gross profit $3b (FY, 2020) |
Net income | Net income N/A | Net income kr6.5b (FY, 2025) | Net income N/A | Net income ($1b) (FY, 2024) | Net income $160.6m (FY, 2020) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog N/A | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog $9.5b (Q3, 2021) |
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 80 (FY, 2023) | Countries 46 (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Zealand Pharma
HQ
Søborg, DK
Employees
385
Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines.
View company
Hansoh Pharma
HQ
Shanghai, CN
Employees
8,989
Hansoh Pharmaceutical Group (翰森制药集团总) is a biopharmaceutical company.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyPPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View company